ArticleJournal for immunotherapy of cancer2022

Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity.

Khalid W Kalim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.